ESTRO 35 2016 _____________________________________________________________________________________________________ with and without shield attenuation using TG43 and were calculated with TG186 fixing the dwell times. It was not possible to perform a TG186 calculation without the shields in place. The TG186 calculation used a HU based mass density and all contoured organs were set to 'female soft tissue' except bladder which was set to 'water' to provide the chemical composition. The HRCTV D90 and D2cc for rectum, bladder, small bowel and sigmoid were recorded and EQD2 doses calculated assuming 50.4Gy in 28 fractions external beam component. Table 1 gives the difference in HRCTV D90 and OAR D2cc doses between the different dose calculations.
The combination of shields and TG186 dose calculation reduced the rectum D2cc by an average of 15.8% (5.6%-31.7%) compared to the TG43 dose calculation with no shields in place. This equates to a reduction in EQD2 of 4.2Gy (0.6Gy-13Gy) and is associated with an average HRCTV EQD2 reduction of 1Gy. The reduction is due to the physical effect of the shielding and the more accurate dose calculation. These results show that the effect of the algorithm is the largest contributor as TG43 underestimates the effect of the shields.
Conclusion:
This study demonstrates that using shielded applicators has the potential to reduce the rectum D2cc. The rectal dose is rarely our dose limiting organ due to the routine use of a rectal retractor, however any reduction in rectal dose would be beneficial. Two patients in this cohort had rectal D2cc doses greater than 70Gy in the clinical plan. For these two patients the shielded TG186 plan reduced the rectal D2cc dose significantly by 5.7Gy and 13Gy compared to the unshielded TG43 plan. Further work is needed to assess the TG186 calculation without shields and the effect of applicator geometry on the position of OARs.
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Post IVD verification and recalibration of MOSkins using a certified low dose emitting Sr-90 source A. Romanyukha Purpose or Objective: In vivo dosimetry (IVD) measurements in HDR brachytherapy (BT) have to be validated by performing a quality assurance check of the functionality of the dosimeters right after the treatment. Recalibration is also usually required due to the high delivered doses per fraction involved. The standard procedure using Ir-192 is burdensome due to limited availability of the operating theater, where the afterloader containing the Ir-192 source is located, as well as due to the transport and setup of the water equivalent phantom. In this work, a procedure involving the use of a certified low dose emitting Sr-90 source was proposed to both perform QA and recalibration of MOSkin dosimeters right after IVD in HDR Ir-192 BT without the need of the BT theater and phantom setup.
Material and Methods:
The MOSkin is a type of MOSFET detector developed at the Centre of Medical Radiation Physics (CMRP) in the University of Wollongong that was integrated into present HDR Ir-192 BT procedures for real time IVD. The standard MOSkin calibration/verification technique employs the Ir-192 source used in HDR procedures, in which case the detector is placed into a water equivalent phantom, and irradiated three times with a known dose. The average of the three measurements is calculated as the calibration coefficient. Instead of using , in this study the use of a certified low dose emitting Sr-90 source was investigated. A very small phantom that allows a fixed position of the detector in relation to the source was established. Three MOSkins were tested at three stages of their lifetime, roughly 15 Gy apart. At each one of these stages, each MOSkin was calibrated by performing three measures both with . The sensitivity ratio of the average values obtained with Sr-90 and Ir192 was calculated for each measurement.
Results: Both Sr-90 and Ir-192 measurements confirmed a small reduction of MOSkin sensitivity with accumulated dose, at 1.1% with every 10 Gy, which is proportional to the change in threshold voltage of the dosimeter to the first order of approximation. The sensitivity ratio of Sr-90 and Ir-192 measurements remained at a constant value of 9.0±0.2% for all three stages of MOSkin life, and among the three dosimeters employed in the experiment.
Conclusion:
A stable proportional relationship was established between the Ir-192 and Sr-90 calibration methods, demonstrating that Sr-90 can be used effectively for MOSkin recalibration as well as for post treatment verification of their functionality after IVD sessions. The procedure involving Sr-90 is much more convenient because it does not necessitate the use of the BT operating theater and can be easily performed everywhere without any particular radioprotection requirements. Additionally it is not necessary to know the dose delivered by to MOSkin but rather the time of irradiation of the MOSkin on each of them respectively, assuming activity changes of Sr-90 are negligible. 
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Material and Methods:
The source position and dwell time accuracy were optically measured using Varian's source step viewer and a videocamera. The Perma-Doc phantom was used for dosimetric verification of the afterloader's source positioning accuracy. The most distal source position and the dead space of the applicators (titanium/stainless steel/ plastic needles, titanium Fletcher-type and flexible tube) were measured radiographically using kV imaging and dosimetrically using EBT3 film. For these measurements an Xray marker and the Ir-192 source were successively inserted into the applicators, respectively. The distance between the external end of the applicators and the center of the most distal X-ray marker and the first dwell position on film were measured (Fig.1) .
Results:
The dwell time deviation measured at different source positions is <0.1s, and is in accordance with vendor specifications. For the most proximal source position, a systematic longer dwell time of 0.13s was observed. This deviation should be negligible when multiple dwell positions are used. Position verification using the source step viewer shows deviations of 0.5-1mm (vendor specs: ± 1mm). At the most distal position, the source was always retracted by 1 mm relative to the nominal position to straighten the source ________________________________________________________________________________ cable. This effect was taken into account during treatment planning. Position verification using the PermaDoc phantom confirmed this 1 mm retraction. All radiographically measured dead spaces complied with the specifications, except for the plastic needles which were 1 mm shorter than indicated. The center of the active source is at 2.42 mm from the tip of the capsule. Combined with the 1 mm source retraction, the center of the dose distribution at the most distal position located always 3.5 mm behind the internal end-point of the source channel. Radiographic and dosimetric dead space measurements showed good agreement (<0.5mm) for all applicators.
Conclusion:
Measured source position and dwell time accuracy comply with the vendor's specifications. Small deviations were found for the dwell time accuracy at the most proximal source position. Similar tests should be performed regularly to warrant the mechanical accuracy of the afterloader and the quality of the applicators and transfer tubes.
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Real-time dosimetry for HDR brachytherapy L. Moutinho Purpose or Objective: Dose verification and quality assurance in radiotherapy (RT) should be assessed in order to provide the best treatment possible and minimize risks for patient. In certain treatments there are no tools capable of performing real-time dose measurement. In addition, in-situ real-time dosimetry would enhance brachytherapy (BT) by providing technical conditions to perform treatment readjustment and real-time dose correction. Considering the current challenges, we developed a dosimeter intended for in-situ and real-time dosimetry in High Dose Rate brachytherapy (HDR-BT), e.g., prostate and breast.
Material and Methods:
The dosimeter developed has a sensitive 3 m long optical fiber probe of 1mm or 0.5 mm diameter comprehending a 5 mm length scintillating optical fiber. To read the signal produced at the probe, 1x1 mm2 Silicon Photomultipliers (SiPM) from Hamamatsu were used. A custom made readout system with SiPM temperature compensation was used. The main concerns when performing dosimetry at high dose rates with high energy isotopes is the eventuality of Cherenkov light production. This form of noise accounts to the total noise signal, known as stem effect. The dosimeter was placed in a PMMA phantom and the response was evaluated with a 10.07 Ci Ir-192 HDRbrachytherapy source (Nucletron). Measurements were repeated twice, first using a dummy probe without scintillator for stem effect quantification and second using an ionization chamber (IC) read by an electrometer for reference.
Results:
The studies carried out allowed assessing the amount of stem effect produced in the optical fiber cable. In the conditions described above, the stem effect contribution is lower than 1% for both 0.5 and 1 mm probes. The measurements of the fiber dosimeter response as a function of the dose are represented in Figure 1 . The small difference from the reference IC is due to the different detector volumes of the fiber dosimeter and the ionization chamber. The dosimeter shows a linear response with dose rate being capable of detecting µGy dose variations. 
